Rolf Ho Bornschein has decided to leave his role as CFO at Clinical Laserthermia Systems
Lund, Sweden – Clinical Laserthermia Systems AB (publ) (CLS) today announces that Rolf Ho Bornschein has decided to move on in his career and will thereby leave his role as CFO at CLS. A process to recruit his successor has been initiated. Rolf Ho Bornschein, who has been CLS’ CFO since October 2022, will continue in his current role during his notice period.“During his time as CFO, Rolf has played an essential role in CLS’ market establishment and commercialization of our laser ablation products in the US, Europe, and Asia-Pacific region as well as for our growth strategy with the ambition